p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2

EMBO Journal

Volumn 20, Issue 6, 2001, Pages 1331-1340

  Ito, Akihiro ^a   Lai, Chun Hsiang ^a   Zhao, Xuan ^a   Saito, Shin'Ichi ^b   Hamilton, Maria H ^a   Appella, Ettore ^b   Yao, Tso Pang ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Acetylation; CBP; MDM2; p300; p53

Indexed keywords

ACYLTRANSFERASE; ANTIMETABOLITE; DACTINOMYCIN; PROTEIN MDM2; PROTEIN P19; PROTEIN P300; PROTEIN P53;

ACETYLATION; ARTICLE; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN STABILITY; STRESS;

ACETYLATION; ACETYLTRANSFERASES; GENES, TUMOR SUPPRESSOR; HUMANS; NUCLEAR PROTEINS; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; SUPPRESSION, GENETIC; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035868964     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/20.6.1331     Document Type: Article

References (46)

1. Signaling to p53: Breaking the posttranslational modification code
2. Stress signals utilize multiple pathways to stabilize p53
3. Regulation of activity of the transcription factor GATA-1 by acetylation
4. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53
5. Mapping of the p53 and mdm-2 interaction domains
6. E1A signaling to p53 involves the pl9(ARF) tumor suppressor
7. Serine 15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2
8. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-KD protein (p300) reveals a protein with properties of a transcriptional adaptor
9. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53
10. Functions of the MDM2 oncoprotein
11. Mutations truncating the EP300 acetylase in human cancers
12. The complexity of p53 modulation: Emerging patterns from divergent signals
13. Conjunction dysfunction: CBP/p300 in human disease
14. CBP/p300 in cell growth, transformation and development
15. p300/MDM2 complexes participate in MDM2-mediated p53 degradation
16. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain
17. Synergistic activation of transcription by CBP and p53
18. DNA damage-induced activation of p53 by the checkpoint kinase Chk2
19. Association of pl9(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
20. Acetylation: A regulatory modification to rival phosphorylation?
21. Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP
22. Phosphorylation of p53 serine 15 increases interaction with CBP
23. Binding and modulation of p53 by p300/CBP coactivators
24. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage
25. Regulation of E2F1 activity by acetylation
26. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
27. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
28. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
29. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation
30. DNA damage activates p53 through a phosphorylation-acetylation cascade
31. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program
32. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
33. The human homologs of checkpoint kinases Chkl and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites
34. Abnormal skeletal patterning in embryos lacking a single Cbp allele: A partial similarity with Rubinstein-Taybi syndrome
35. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53
36. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2
37. A role for ATR in the DNA damage-induced phosphorylation of p53
38. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2
39. Histone acetylation: Chromatin in action
40. Nucleolar Arf sequesters Mdm2 and activates p53
41. Drosophila ultraspiracle modulates ecdysone receptor function via heterodimer formation
42. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300
43. Activation of p53 or loss of the Cockayne syndrome group B repair protein causes metaphase fragility of human U1, U2 and 5S genes
44. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53
45. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
46. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization